Important Updates on COVID-19

As the COVID-19 (coronavirus) pandemic continues to evolve around the world, Otsuka stands united with our global community to navigate this fast moving and complex healthcare event.

Read the full statement
Neurovance, Inc. is now an indirect, wholly-owned subsidiary of Otsuka Pharmaceutical Co., Ltd. (OPC). To learn more about this acquisition, please read the press release on the Otsuka U.S. website.